Roopa Achuri
Physician Assistant · Neenah, WINPI 1225531635
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,209, more than ten times the $265 reported in 2021. Among physician assistant clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Johnson & Johnson$1K
- GSK$1K
- AbbVie$841
- Pfizer$670
- Novartis$661
- plus $4K from 25 others
What the payments were for
- Food & beverage$9,56897%
- Education$2483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 84 | $1,890 |
| Johnson & Johnson(2 entities) | 38 | $1,095 |
| GSK | 18 | $1,046 |
| AbbVie | 56 | $841 |
| Pfizer | 31 | $670 |
| Novartis | 30 | $661 |
| Radius Health, Inc. | 16 | $439 |
| AstraZeneca(2 entities) | 14 | $418 |
| UCB, Inc. | 20 | $400 |
| Lilly USA, LLC | 14 | $389 |
| Boehringer Ingelheim | 12 | $292 |
| Aurinia Pharma U.S., Inc. | 8 | $249 |
| E.r. Squibb & Sons, L.L.C. | 8 | $194 |
| Organon | 11 | $190 |
| ANI Pharmaceuticals, Inc. | 5 | $138 |
| Sobi, Inc | 5 | $128 |
| Sandoz | 7 | $127 |
| Fresenius Kabi USA, LLC | 8 | $125 |
| Genentech USA, Inc. | 4 | $86 |
| Tersera Therapeutics LLC | 3 | $60 |
| Mallinckrodt Hospital Products Inc. | 2 | $58 |
| Pharming Healthcare, Inc. | 3 | $58 |
| Bioventus LLC | 3 | $54 |
| Octapharma USA, Inc. | 2 | $43 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Invivyd Inc | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,816 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 37 | $231,386 |
| KevzaraSarilumab | 36 | $166,672 |
| RinvoqUpadacitinib | 13 | $115,074 |
| Enbrel SureclickEtanercept | 12 | $102,990 |
| Orencia ClickjectAbatacept | 16 | $100,938 |
| XeljanzTofacitinib Citrate | 17 | $97,452 |
| Cimzia (2 Pack)Certolizumab Pegol | 13 | $76,580 |
| EnbrelEtanercept | 11 | $72,794 |
| OrenciaAbatacept | 12 | $67,166 |
| ProliaDenosumab | 11 | $19,251 |
| Hydroxychloroquine Sulfate | 316 | $13,892 |
| Celecoxib | 231 | $8,109 |
| MethotrexateMethotrexate Sodium | 226 | $5,141 |
| Cevimeline Hcl | 25 | $3,942 |
| Mycophenolate Mofetil | 35 | $2,746 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $841 | $115,07413 claims |
| PfizerXeljanz | $670 | $97,45217 claims |
| AmgenEnbrel, Prolia | $1,890 | $92,04522 claims |
| UCB, Inc.Cimzia (2 Pack) | $400 | $76,58013 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $194 | $67,16612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Other physician assistant in Neenah
- Christina NagleNeenah$18K
- David KuphalNeenah$17K
- Sara HollandMadison$189K
- Lisa SershonMilwaukee$182K
- Sarah VicariFranklin$120K
- Jessica SzpakBaraboo$95K
- Amy BurmeschMenomonee Falls$79K
- Eric GoddeyneGreen Bay$61K
- Charnai SherryMilwaukee$45K
- Victoria MaloneyWauwatosa$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.